Skip to main content
Caplight Logo









miRoncol Health

miRoncol Health

Private
OttawaHealthcare & Life Scienceshttps://mironcol.com/

Last Round

Accelerator

May 1, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

miRoncol Health is a biotechnology company that develops a multi-cancer risk assessment blood test designed for early cancer detection using microRNA and machine learning.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics

Business Model

B2C

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

multi-cancer early detectionMCEDliquid biopsymicroRNAcancer risk assessmentAI diagnosticscancer screeningprecision medicinepreventive healthbiotechlongevity clinicmolecular diagnosticshealthtechcancer blood testearly detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

miRoncol Health Comparables

Compare miRoncol Health with similar companies based on industry and business-model similarity.

miRoncol Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dxcover
78%
Flomics Biotech
76%
Craif Inc.
74%

miRoncol Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 1, 2026

Key People

Founding team and executive leadership

Victoria Xu

Chief Executive Officer, Member Board Of Directors

Executive Team

miRoncol Health Investors

Notable investors and investment history

miRoncol Health investors
InvestorRounds
Innovation FactoryAccelerator
Archangel Network of FundsAccelerator, Seed
SpringAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors grew 104% MoM, reaching 1.5K.

  • May 1, 2026

    Raised an Accelerator round with Archangel Network of Funds, Innovation Factory, and Spring.

miRoncol Health Filings

Explore SEC and related filing metadata, where available.

miRoncol Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about miRoncol Health's valuation, stock price, and market status.

Is miRoncol Health a public or private company?

miRoncol Health is a private company.

What is the current stock price of miRoncol Health?

miRoncol Health is a private company with no public stock price. No recent secondary market data is available.

How much is miRoncol Health worth (valuation)?

Valuation information for miRoncol Health is not publicly available.

Can I buy miRoncol Health stock?

miRoncol Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was miRoncol Health's last funding round?

Funding round information for miRoncol Health is not publicly available.

Who are the main investors in miRoncol Health?

Key investors in miRoncol Health include Archangel Network of Funds.

Will miRoncol Health IPO soon?

No public IPO plans have been announced for miRoncol Health.

How can I track miRoncol Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor miRoncol Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOttawa
Employee Range9
Year Founded2021
Last FundingMay 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?